The global RNA interference (RNAi) therapeutics market is emerging as a transformative segment within the biotechnology and pharmaceutical industries, driven by its potential to silence disease-causing genes at the molecular level. RNAi therapeutics represent a breakthrough approach in precision medicine, enabling targeted treatment of genetic disorders, rare diseases, and chronic conditions...
SPARK Website
English